A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

By Chim C.   Lie A.   Chan E.   Leung Y.   Cheung S.   Chan S.   Liang Raymond   Kwong Y.  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1019-1027

Springer Publishing Company

Access to resources Recommend Favorite

Stem cell transplantation in multiple myeloma

By Björkstrand Bo  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 26-28

Maney Publishing

Access to resources Recommend Favorite

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide

By Witzens Mathias  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 467-470

Springer Publishing Company

Access to resources Recommend Favorite

Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma

By Wang M.   Giralt S.   Delasalle K.   Handy B.   Alexanian R.  

Hematology, Vol. 12, Iss. 3, 2007-06 ,pp. : 235-239

Maney Publishing

Access to resources Recommend Favorite

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

By Lee C.-K.   Badros A.   Barlogie B.   Morris C.   Zangari M.   Fassas A.   van Rhee F.   Cottler-Fox M.   Jacobson J.   Thertulien R.   Muwalla F.   Mazher S.   Anaissie E.   Tricot G.  

Experimental Hematology, Vol. 31, Iss. 1, 2003-01 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite